Valuation: Olympus Corporation

Market Cap 1,869B 11.77B 10.58B 9.87B 8.95B 16.8B 1,120B 16.91B 119B 46.27B 581B 44.18B 43.23B P/E 2027 *
17.9x
P/E 2028 * 15.4x
Enterprise Value 1,953B 12.3B 11.06B 10.32B 9.35B 17.56B 1,170B 17.67B 124B 48.35B 607B 46.17B 45.17B EV / Sales 2027 *
1.8x
EV / Sales 2028 * 1.72x
Free-Float
94.58%
Yield 2027 *
1.74%
Yield 2028 * 1.82%
1 day-2.16%
1 week-13.52%
Current month-14.57%
1 month-12.86%
3 months-1.49%
6 months+6.60%
Current year-13.28%
1 week 1,693
Extreme 1693
2,048.5
1 month 1,693
Extreme 1693
2,048.5
Current year 1,302.5
Extreme 1302.5
2,210.5
1 year 1,302.5
Extreme 1302.5
2,210.5
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 64 01/06/2025
Director of Finance/CFO 59 01/04/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 41 01/06/2019
Director/Board Member 63 01/06/2019
Director/Board Member 59 25/06/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.16%-13.52%-5.05%-11.04% 11.77B
+1.53%+1.68%+28.03%+39.42% 249B
+0.83%+2.84%+8.99%+7.29% 158B
-0.43%+1.38%-3.70%+53.85% 148B
-0.72%+3.42%-55.32%-13.17% 62.32B
+0.90%+5.36%-14.45%-15.44% 49.61B
+1.38%+0.78%+17.84%+22.14% 49.83B
-1.42%+5.26%+3.37%+37.59% 48.14B
+1.40%+2.90%+26.05%+57.45% 49.06B
+1.73%+0.14%+31.06%+72.84% 42.9B
Average +0.32%+0.78%+3.68%+25.09% 86.89B
Weighted average by Cap. +0.25%+1.76%+8.38%+30.03%

Financials

2027 *2028 *
Net sales 1,082B 6.81B 6.13B 5.72B 5.18B 9.73B 648B 9.79B 68.6B 26.79B 336B 25.58B 25.02B 1,123B 7.07B 6.36B 5.93B 5.38B 10.09B 673B 10.15B 71.17B 27.79B 349B 26.54B 25.96B
Net income 105B 664M 597M 557M 505M 948M 63.2B 954M 6.69B 2.61B 32.8B 2.49B 2.44B 122B 767M 689M 643M 583M 1.09B 72.94B 1.1B 7.72B 3.01B 37.86B 2.88B 2.82B
Net Debt 83.87B 528M 475M 443M 401M 754M 50.24B 758M 5.32B 2.08B 26.08B 1.98B 1.94B 65.49B 412M 371M 346M 314M 589M 39.23B 592M 4.15B 1.62B 20.36B 1.55B 1.51B
Projected Income Statement - Annual - Olympus Corporation
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
15/10/26 JP¥1,721.00 -2.16% 8,050,200
14/10/26 JP¥1,759.00 -13.46% 13,441,400
13/10/26 JP¥2,032.50 +1.62% 4,055,200
09/10/26 JP¥2,000.00 +0.50% 4,568,200
08/10/26 JP¥1,990.00 -0.50% 3,998,700
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Olympus Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
1,759.00JPY
Average target price
2,123.08JPY
Spread / Average Target
+20.70%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Olympus Corporation
  1. Stock Market
  2. Stocks
  3. 7733 Stock